TNF and steatosis: In a study by Lin and colleagues, it was found that Met can improve fatty liver disease by reversing hepatomegaly, steatosis and aminotransferase abnormalities by inhibiting hepatic expression of tumoral necrosis factor (TNF) and TNF-inducing factors that promote the accumulation of liver lipids [38].